94 results
8-K
EX-99.1
VERV
Verve Therapeutics Inc
8 May 24
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
7:15am
will advance the research and development of the Lp(a) program through the completion of Phase 1 clinical development. Lilly will be responsible
8-K
EX-1.1
y6gjo0mv gle614
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm